Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT02415621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02415621
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-13
- Primary completion
- 2019-08-12
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.